Communiqués Center Laboratories, Inc.

Actions

4123

TW0004123005

Produits pharmaceutiques

Cours en clôture Taipei Exchange 24/09/2026			Varia. 5j.	Varia. 1 janv.
30,95 ^TWD	-1,75%		+0,16%	-21,89%

11/08	Center Laboratories, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
13/05	Center Laboratories annonce un bénéfice net de 1,97 milliard de TWD au premier trimestre	RE

Communiqués

11/08/22	Center Laboratories : To announce the ex-rights and dividend record date and the closure period for the conversion of CB4 and CB5	PU
10/08/22	Center Laboratories : Amendment on the Company's 2021 Annual Report	PU
27/07/22	Center Laboratories : Announcement on the change of internal audit officer	PU
27/07/22	Center Laboratories : Announcement on the Company’s board resolution to the removal of non-compete restrictions on manager	PU
27/07/22	Center Laboratories : Announcement on the Company's board resolution to increase the investment on Mycenax Biotech Inc	PU
14/07/22	Center Laboratories : The Company cooperated with the Ministry of Justice Investigation Bureau's investigation as a third party.	PU
29/06/22	Center Laboratories : Announcement on changing the effective date of the merger between the Company and its subsidiary Bioengine Capital Inc.	PU
08/06/22	Center Laboratories : Correction made on the Company’s Consolidation Financial Report for the Q1 2022 filled to the Mops	PU
31/05/22	Center Laboratories : Announcement on the Company’s Board resolution to increase the investment on TOT Biopharm International Company Limited	PU
20/05/22	Center Laboratories : The Board of Directors approved to appoint the members of 5th Remuneration Committee	PU
20/05/22	Center Laboratories : To announce newly appoint members of the 2nd term of Audit Committee.	PU
20/05/22	Center Laboratories : The Company's 2022 Annual Shareholders' Meeting approved the release of non-competition restrictions on newly elected Directors	PU
20/05/22	Center Laboratories : Lin, Jung Chin is elected as Chairman by the Board of Directors	PU
20/05/22	Center Laboratories : Announcement of the appointment of representative by the newly elected institutional director	PU
20/05/22	Center Laboratories : To announce the major resolutions of 2022 Annual Shareholders' Meeting	PU
20/05/22	Center Laboratories : To announce Directors elected by 2022 Annual Shareholders’Meeting	PU
13/04/22	Center Laboratories : Explanation of the difference between the self -closing declarations of related party transactions and the audited review by CPA for the fourth quarter of 2021	PU
07/04/22	Center Laboratories : Announcement the Board of Directors resolved the merger of subsidiary, Bioengine Capital Inc.	PU
07/04/22	Center Laboratories : The Board resolved to convene 2022 Annual General Shareholders’Meeting (Agenda new added)	PU
07/04/22	Center Laboratories : Announcement on behalf of subsidiary, BioEngine Capital Inc, Merged with parent company.	PU
07/04/22	Center Laboratories : Announcement of the BOD's rejection on the private placement of common shares after the expiration date according to the resolution of AGM on July 1, 2021	PU
01/04/22	Center Laboratories : Announcement on the board resolution to purchase stocks from Bioengine Capital Inc.	PU
01/04/22	Center Laboratories : Announcement of contents of the matter that has not been passed by the Audit Committee, but approved by two-thirds or more of the Board of Directors	PU
22/03/22	Center Laboratories : The Board resolved to convene 2022 Annual General Shareholders’Meeting (Agenda new added)	PU
22/03/22	Center Laboratories : The Board of Directors resolved to Issue new common shares for capital increase out of earnings.	PU